Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): Study of 40 cases

Blood

Volumn 114, Issue 23, 2009, Pages 4777-4783

  Psaila, Bethan ^a,b   Petrovic, Aleksandra ^c   Page, Lemke K ^a   Menell, Jill ^d   Schonholz, Matthew ^a   Bussel, James B ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c All Children's Hospital   (United States)

^d ST JOSEPH S REGIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN; RHESUS D ANTIBODY; STEROID; CORTICOSTEROID;

ADOLESCENT; ARTICLE; BRAIN HEMORRHAGE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; ECCHYMOSIS; FEMALE; HEAD INJURY; HEALTH SURVEY; HEMATURIA; HIGH RISK POPULATION; HUMAN; IMMUNE THROMBOCYTOPENIA; INFANT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PETECHIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; CASE CONTROL STUDY; CHRONIC BRAIN DISEASE; CRANIOTOMY; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INCIDENCE; MULTIMODALITY CANCER THERAPY; RISK; SURVIVAL; UNITED STATES; UTILIZATION REVIEW;

ADOLESCENT; ADRENAL CORTEX HORMONES; BRAIN DAMAGE, CHRONIC; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CRANIOCEREBRAL TRAUMA; CRANIOTOMY; FEMALE; HEALTH SURVEYS; HEMATURIA; HUMANS; INCIDENCE; INFANT; INTRACRANIAL HEMORRHAGES; MALE; PLATELET COUNT; PLATELET TRANSFUSION; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RISK; SPLENECTOMY; SURVIVAL ANALYSIS; UNITED STATES;

EID: 74049128730     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-04-215525     Document Type: Article

References (31)

1. Medeiros D, Buchanan GR. Major hemorrhage in children with idiopathic thrombocytopenic purpura: Immediate response to therapy and longterm outcome. J Pediatr. 1998;133(3):334-339.
2. Neunert CE, Buchanan GR, Imbach P, et al. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood. 2008;112(10):4003-4008.
3. Butros LJ, Bussel JB. Intracranial hemorrhage in immune thrombocytopenic purpura: a retrospective analysis. J Pediatr Hematol Oncol. 2003;25(8):660-664.
4. Zeller B, Rajantie J, Hedlund-Treutiger I, et al. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: Epidemiology and predictors of chronic disease. Acta Paediatr. 2005;94(2):178-184.
5. Fogarty P, Segal J. The epidemiology of immune thrombocytopenic purpura. Curr Opin Hematol. 2007;14(5):515-519.
6. Krivit W, Tate D, White JG, Robison LL. Idiopathic thrombocytopenic purpura and intracranial hemorrhage. Pediatrics. 1981;67(4):570-571.
7. Iyori H, Bessho F, Ookawa H, et al. Intracranial hemorrhage in children with immune thrombocytopenic purpura. Ann Hematol. 2000;79(12):691-695.
8. Arya LS, Jain Y, Narain S, Choudhry VP, Pati HP. Spontaneous intracranial hemorrhage in children with immune thrombocytopenic purpura. Indian Pediatr. 2002;39(5):468-472.
9. Choudhary DR, Naithani R, Mahapatra M, Kumar R, Mishra P, Saxena R. Intracranial hemorrhage in childhood immune thrombocytopenic purpura. Pediatr Blood Cancer. 2009;52(4):529-531.
10. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88(1):3-40.
11. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions, and outcome criteria in immune thrombocytopenic purpura (ITP) of adults and children: Report from an International Working Group. Blood. 2009;113(11)2386-2393.
12. US Census Bureau. Resident Population Estimates of the United States by Age and Sex. Vol 2008. Washington, DC: US Government, 2006.
13. Lilleyman JS. Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Arch Dis Child. 1994;71:251-253.
14. Imbach P, Kuhne T, Zimmerman S. New developments in idiopathic thrombocytopenic purpura (ITP): cooperative, prospective studies by the Intercontinental Childhood ITP Study Group. J Pediatr Hematol Oncol. 2003;25(suppl 1):S74-S76.
15. Page LK, Psaila B, Provan D, et al. The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP. Br J Haematol. 2007;138(2):245-248.
16. Lee MS, Kim WC. Intracranial hemorrhage associated with idiopathic thrombocytopenic purpura: Report of seven patients and a meta-analysis. Neurology. 1998(50):1160-1163.
17. Tarantino MD, Young G, Bertolone SJ, et al. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children. J Pediatr. 2006;148(4):489-494.
18. Bolton-Maggs PH. Acute idiopathic thrombocytopenic purpura: Management in childhood. Blood. 1997;89(4):1465.
19. Buchanan GR. The nontreatment of childhood idiopathic thrombocytopenic purpura. Eur J Pediatr. 1987;146(2):107-112.
20. Dickerhoff R, von Ruecker A. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment. J Pediatr. 2000;137(5):629-632.
21. Tarantino MD. On the conservative management of acute immune thrombocytopenia in children. J Pediatr. 2001;138(5):787-788.
22. Sutor AH, Harms A, Kaufmehl K. Acute immune thrombocytopenia (ITP) in childhood: Retrospective and prospective survey in Germany. Semin Thromb Hemost. 2001;27(3):253-267.
23. Sutor AH. Acute immune thrombocytopenia in childhood: Are we treating the platelet count? Semin Thromb Hemost. 1998;24(6):545-548.
24. Tarantino MD, Bolton-Maggs PH. Update on the management of immune thrombocytopenic purpura in children. Curr Opin Hematol. 2007;14(5):526-534.
25. Boruchov DM, Gururangan S, Driscoll MC, Bussel JB. Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP). Blood. 2007;110(10):3526-3531.
26. Bussel JB, Kuter DJ, George JN, et al. AMG 531, a thrombopoiesis- stimulating protein, for chronic ITP. N Engl J Med. 2006;355(16):1672-1681.
27. Figueroa M, Gehlsen J, Hammond D, et al. Combination chemotherapy in refractory immune thrombocytopenic purpura. N Engl J Med. 1993;328(17):1226- 1229.
28. Bussel JB, Cheng G, Saleh MN, et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med. 2007;357(22):2237- 2247.
29. Kuter DJ, Bussel JB, Lyons RM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: A double-blind randomised controlled trial. Lancet. 2008;371(9610):395-403.
30. Kalpatthi R, Bussel JB. Diagnosis, pathophysiology and management of children with refractory immune thrombocytopenic purpura. Curr Opin Pediatr. 2008;20(1):8-16.
31. Psaila B, Bussel JB. Refractory immune thrombocytopenic purpura: Current strategies for investigation and management. Br J Haematol. 2008;143(1):16-26.